跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,069 条关于
“REX-8756”
全部
3,069
临床试验
2,218
药物
576
机构
69
资讯
206
4个月前
Recludix's Oral STAT6 Inhibitor REX-8756 Shows Efficacy Comparable to Monoclonal Antibodies in Atopic Dermatitis Model
9个月前
Recludix Pharma Receives FDA Clearance for First-in-Class Oral STAT6 Inhibitor REX-8756 to Enter Phase 1 Testing
去年
ScaleReady Awards G-Rex Grants to Advance Novel CAR-T Cell Therapy Manufacturing
去年
LIfT Biosciences Awarded ScaleReady G-Rex Grant to Advance N-LIfT Cell Therapy Manufacturing
去年
Arovella Therapeutics Secures $20M to Advance ALA-101 Clinical Trial and iNKT Cell Therapy Pipeline
去年
Reprieve Cardiovascular Secures $61 Million Series B Funding, Initiates Pivotal Heart Failure Trial
去年
UPMC Enterprises Leads $18.25 Million Series B1 Investment in Carta Healthcare for AI-Powered Clinical Data Management
去年
Critical Limb Ischemia Market Projected to Reach $2.5 Billion by 2035, Driven by Novel Therapies and Advanced Diagnostics
上个月
Alabama Teenager Will Roberts, Whose Viral Plea for Bone Cancer Drug Captured National Attention, Dies at 15
去年
Humacyte Plans Q4 IND Filing for Coronary Tissue Engineered Vessel Following Promising Primate Study
第 1 页,共 21 页
上一页
下一页